George Church spinoff swallows a key manufacturing partner as it preps CRISPR-edited pig organs for animal testing

Amber Tong

Researching, cloning and breeding gene-edited pigs are core to eGenesis’ audacious mission to grow organs that can be xenotransplanted into humans. But perhaps unsurprisingly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

George Church spinoff swallows a key manufacturing partner as it preps CRISPR-edited pig organs for animal testing

Amber Tong

Sign up to read this article for free.

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

US drugs rely heavily on ingredients made overseas, new report shows

Sarepta loses CMO to RNA editing upstart; Another wave of personnel moves at Dyne

Exclusive: VelaVigo inks another US biotech deal as China drug development scene booms

Biotech seed rounds sink to lowest level in years as industry slump drags on

New York-based partnership sets the standard for expanding clinical trial access for underserved and diverse ...

George Church spin­off swal­lows a key man­u­fac­tur­ing part­ner as it preps CRISPR-edit­ed pig or­gans for an­i­mal test­ing

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

George Church spinoff swallows a key manufacturing partner as it preps CRISPR-edited pig organs for animal testing